Classen Immunotherapies, Inc. Company Profile

04:17 EST 19th December 2018 | BioPortfolio

Tel: 410-377-8526

News Articles [157 Associated News Articles listed on BioPortfolio]

New hurdle for developing immunotherapies

A new discovery tosses a new wrench into the process of building better molecules to develop immunotherapies.

Rethinking RECIST for immunotherapies

Momentum is growing among companies, research institutions and FDA for new response criteria that better reflect the benefits of immunotherapies.

eTheRNA opens mRNA manufacturing facility in Belgium to support production of mRNA cancer immunotherapies

eTheRNA immunotherapies, a clinical─stage company developing novel cancer immunotherapies based on its proprietary mRNA─based TriMix platform, announces the opening of a state─of─the─art mRN...

Study Uncovers New Hurdle for Developing Immunotherapies

NewsAn unexpected finding tosses a new wrench into the process of building better molecules to develop immunotherapies.

Merck and Dragonfly partner to develop cancer immunotherapies

Merck has formed a strategic alliance with Dragonfly Therapeutics to discover, develop and commercialise new immunotherapies for the treatment of...Read More... The post Merck and Dragonfly partner to...

Cancer immunotherapies drugs market set for substantial growth, says GBI Research

Increased uptake of immune checkpoint inhibitors drives growth The global market for cancer immunotherapies currently tops $33 billion in value,...Read More... The post Cancer immunotherapies drugs ma...

Collaboration Worth Over €1Bn Could Give Rise to New Cancer Immunotherapies

Genmab is partnering with the German company Immatics to develop immunotherapies directed against three cancer targets. Genmab has offered Immatics, based in Tuebingen, Germany, an upfront payment of ...

Modified natural killer cells may be new player in CAR-T immunotherapies

Emerging CAR-T immunotherapies leverage modified versions of patient's T-cells to target and kill cancer cells.

Drugs and Medications [0 Results]


PubMed Articles [74 Associated PubMed Articles listed on BioPortfolio]

Checkpoint-modulating immunotherapies in tumor treatment: Targets, drugs, and mechanisms.

Tumor immunotherapy, as a new treatment of cancer, has been developing on the basis of tumor immunology. Tumor immunotherapy stimulates and enhances the function of immune system in human bodies, in o...

Toxicities with targeted therapies after immunotherapy in metastatic melanoma.

Over the last decade, melanoma treatment has taken rapid strides with the advent of immunotherapies and targeted agents. With these new agents, there has been a significant improvement in patient surv...

Management of peanut allergy: a focus on novel immunotherapies.

The management of peanut allergy involves strict avoidance, prompt recognition of allergic reactions, and rapid initiation of epinephrine and other supportive therapy for anaphylaxis. Avoidance presen...

Animal Models for Studying Tumor Microenvironment (TME) and Resistance to Lymphocytic Infiltration.

In cancer immunotherapy, cytotoxic T or NK cells need to engage cancer cells to initiate the killing. However, in clinical studies and in mouse models, some solid tumors are found with no lymphocytes....

Novel Immunotherapies for T Cell Lymphoma and Leukemia.

Novel immunotherapies such as checkpoint inhibitors, bispecific antibodies, and chimeric antigen receptor T cells are leading to promising responses when treating solid tumors and hematological malign...

Clinical Trials [32 Associated Clinical Trials listed on BioPortfolio]

A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies

This is a Phase 1b/2 dose-optimization study to evaluate safety, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of avelumab (MSB0010718C) in combination with other ...

Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1

Recent scientific advances have shown the important role of immune system against cancer. Today, many immunological biotherapy like anti-PD1/PDL-1 are available in cancer treatment and gen...

GI-4000 With Adoptive Transfer in Pancreatic Cancer

The purpose of this study is to determine if it is safe to add multiple immunotherapies to standard chemotherapy and radiation for treating pancreatic cancer tumors that cannot be complete...

Prospective Tissue Collection Research Protocol

This study aims to collect matched donor tissue and blood to enable the development of a manufacturing process for potential immunotherapies.

Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies

The co-primary objectives will be to assess the safety and quality of life under treatment.

Companies [52 Associated Companies listed on BioPortfolio]

Classen Immunotherapies, Inc.

Tel: 410-377-8526

CTL ImmunoTherapies

CTL ImmunoTherapies, located in Chatsworth, California, is a biotechnology company focusing on the discovery, development and manufacturing of theraputic vaccines.

Advaxis, Inc. and Rodman & Renshaw, LLC

Advaxis is a biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform tech...

Checkmate Pharmaceuticals Inc.

Checkmate Pharmaceuticals is a clinical stage company that is leveraging its expertise in the field of CpG oligonucleotides to discover and develop immunotherapies designed to inc...

Selexis SA and OSE Immunotherapeutics SA

Our ambition is to become a world leader in activation and regulation immunotherapies: OSE Immunotherapeutics is a biotechnology company led by world-class immunologists and focus...

More Information about "Classen Immunotherapies, Inc." on BioPortfolio

We have published hundreds of Classen Immunotherapies, Inc. news stories on BioPortfolio along with dozens of Classen Immunotherapies, Inc. Clinical Trials and PubMed Articles about Classen Immunotherapies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Classen Immunotherapies, Inc. Companies in our database. You can also find out about relevant Classen Immunotherapies, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record